Dana Large Cap Equity
As of: August 29, 2018
Large Cap Equity Fund
Fund Information
as of 9/30/22
| SYMBOL (I CLASS/N CLASS) | DLCIX / DLCEX |
| INCEPTION DATE (I CLASS/N CLASS) | 10/28/13 / 3/1/10 |
| BENCHMARK | S&P 500 INDEX |
| TOTAL FUND AUM | $95.1 MM |
| TOTAL FIRM AUM | $6.5 BN |
| MIN. INVESTMENT(I CLASS/N CLASS) | $1MM / $1,000 |
| NET EXP. RATIO (I CLASS/N CLASS) | 0.73% / 0.98% |
| GROSS EXP. RATIO (I CLASS/N CLASS) | 0.86% / 1.11% |
| TARGET CASH POSITION | 0 – 1% |
| INDIVIDUAL SECURITY LIMIT | < 4% |
| SECTOR LIMITS | SECTOR NEUTRAL |
Data source: Morningstar Direct; The net expense ratio of the Class N is 0.98% and 0.73% for Class I, while the gross expense ratio of the Class N is 1.11% and for 0.86% Class I. The Adviser has contractually agreed to waive its management fee and/or reimburse certain operating expenses through 02/28/2023. Results shown reflect the waiver, without which the results would have been lower.
Top Holdings
as of 9/30/22, subject to change. Current and future portfolio holdings are subject to risk.
| Apple, Inc. | 4.07% |
| Microsoft Corporation | 3.68% |
| Alphabet, Inc. Cl A | 3.34% |
| Amazon.com, Inc. | 3.33% |
| Merck & Co., Inc. | 2.54% |
| CVS Health Corp | 2.51% |
| UnitedHealth Group, Inc. | 2.23% |
| CDW Corp. | 2.20% |
| AbbVie, Inc. | 2.17% |
| TE Connectivity Ltd. | 2.04% |